Guizhou Bailing Group Pharmaceutical Co., Ltd. (SHE:002424)

China flag China · Delayed Price · Currency is CNY
5.36
-0.03 (-0.56%)
Jul 22, 2025, 2:45 PM CST
54.47%
Market Cap7.30B
Revenue (ttm)3.25B
Net Income (ttm)6.10M
Shares Out1.37B
EPS (ttm)0.00
PE Ratio1,197.86
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume24,595,764
Average Volume72,175,567
Open5.39
Previous Close5.39
Day's Range5.34 - 5.41
52-Week Range3.12 - 6.15
Beta0.62
RSI59.11
Earnings DateAug 20, 2025

About SHE:002424

Guizhou Bailing Group Pharmaceutical Co., Ltd. research, develops, produces, and sells medicines in China. The company provides medicines in the form of tablets, capsules, granules, syrups, powders, pills, tinctures, sprays, lotions, and cream for cardiovascular and cerebrovascular diseases, cough, cold, pediatric, and gynecologic diseases. Guizhou Bailing Group Pharmaceutical Co., Ltd. was founded in 1999 and is headquartered in Anshun, China. [Read more]

Sector Healthcare
Founded 1999
Employees 6,586
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002424
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.